Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About CCRD Interactive Breakdown Better Bets vs. CCRD Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

CoreCard (CCRD)

Market Price (10/31/2025): $23.66 | Market Cap: $184.3 Mil
Sector: Information Technology | Industry: Application Software

CoreCard (CCRD)

Market Price (10/31/2025): $23.66
Market Cap: $184.3 Mil
Sector: Information Technology
Industry: Application Software

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -16%		 Weak multi-year price returns
2Y Excs Rtn is -48%, 3Y Excs Rtn is -73%		 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.9%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 24%		  
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 14%		  
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -16%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 24%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 14%
3 Weak multi-year price returns
2Y Excs Rtn is -48%, 3Y Excs Rtn is -73%
4 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.9%

Market Valuation & Key Metrics

CCRDS&P 500
REVENUE GROWTHGOOD
Rev LTM ($ Bil)0.1
Rev Chg Q27.5%6.4%
Rev Chg LTM23.6%5.4%
Rev Chg 3Y Avg0.9%5.3%
PROFITABILITYFAIR
Op Inc LTM ($ Bil)0.0
CFO LTM ($ Bil)0.0
Net Inc LTM ($ Bil)0.0
Op Mgn LTM15.9%18.7%
CFO/Rev LTM21.9%20.4%
Net Inc Mgn12.4%12.8%
VALUATIONMODERATE
P/S2.83.2
P/CFO13.015.5
P/FCF20.720.6
P/E23.023.6
STABILITYVERY GOOD
Debt/Equity0.020.21
Cash/Assets0.450.07

CCRD Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 21.2% change in CCRD stock from 5/1/2025 to 10/30/2025 was primarily driven by a 30.3% change in the company's Net Income Margin (%).

501202510302025Change
Stock Price ($)19.4723.6021.21%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)57.4064.8112.91%
Net Income Margin (%)9.49%12.36%30.25%
P/E Multiple27.9822.95-18.00%
Shares Outstanding (Mil)7.837.790.51%
Cumulative Contribution21.21%

LTM = Last Twelve Months as of date shown
The 68.8% change in CCRD stock from 10/30/2024 to 10/30/2025 was primarily driven by a 307.6% change in the company's Net Income Margin (%).

1030202410302025Change
Stock Price ($)13.9823.6068.81%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)52.4364.8123.61%
Net Income Margin (%)3.03%12.36%307.65%
P/E Multiple71.0822.95-67.72%
Shares Outstanding (Mil)8.087.793.63%
Cumulative Contribution68.59%

LTM = Last Twelve Months as of date shown
The -3.7% change in CCRD stock from 10/31/2022 to 10/30/2025 was primarily driven by a -51.6% change in the company's Net Income Margin (%).

1031202210302025Change
Stock Price ($)24.5023.60-3.67%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)65.4764.81-1.01%
Net Income Margin (%)25.54%12.36%-51.59%
P/E Multiple12.6022.9582.19%
Shares Outstanding (Mil)8.607.799.37%
Cumulative Contribution-4.52%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
CCRD Return0%-3%-25%-52%64%4%-35%
Peers Return13%-2%-7%6%52%-19%35%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
CCRD Win Rate50%50%42%33%67%44% 
Peers Win Rate13%10%5%21%33%48% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
CCRD Max Drawdown-37%-24%-47%-55%-25%-24% 
Peers Max Drawdown-5%-4%-8%-1%-4%-34% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADSK, HIT, BIYA, BLIV, BMR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventCCRDS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-75.4%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven306.1%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-44.0%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven78.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven326 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-47.3%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven89.7%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven57 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-87.4%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven694.6%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven2816 days1480 days

Compare to ADSK, HIT, BIYA, BLIV, BMR


In The Past

CoreCard's stock fell -75.4% during the 2022 Inflation Shock from a high on 2/8/2021. A -75.4% loss requires a 306.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About CoreCard (CCRD)

Better Bets than CoreCard (CCRD)

 CCRDBetter Performance than CCRD
MetricValueIndustry (Application Software)
Rev Chg LTM23.6%PLTR (38.8%), SHOP (29.0%), SNOW (28.4%), DDOG (26.0%), MNDY (30.2%)
Rev Chg 3Y Avg0.9%ORCL (10.2%), PLTR (25.7%), SAP (8.5%), CRM (10.5%), SHOP (26.0%)
Op Mgn LTM15.9%ORCL (31.6%), PLTR (16.6%), SAP (26.4%), CRM (21.2%), INTU (26.2%)
CFO/Rev LTM21.9%ORCL (36.5%), PLTR (50.3%), CRM (33.3%), INTU (33.0%), ADBE (42.2%)
FCF/Rev LTM13.8%PLTR (49.7%), SAP (17.7%), CRM (31.6%), SHOP (18.1%), INTU (32.3%)
Total Yield4.4%ADBE (4.8%), MSTR (6.8%), ZM (4.7%), SSNC (5.1%), OTEX (7.2%)
 CCRDBetter Performance than CCRD
MetricValueAll Other Sectors
Rev Chg LTM23.6%LLY (36.8%), APP (48.2%), HOOD (59.6%), WELL (32.6%), MELI (35.8%)
Rev Chg 3Y Avg0.9%GOOGL (11.0%), AMZN (11.3%), META (17.3%), TSLA (9.3%), JPM (13.5%)
Op Mgn LTM15.9%GOOGL (32.2%), META (43.2%), LLY (43.0%), V (66.5%), MA (58.0%)
CFO/Rev LTM21.9%GOOGL (39.3%), META (56.8%), V (60.4%), MA (53.3%), NFLX (22.1%)
FCF/Rev LTM13.8%GOOGL (19.1%), META (23.7%), V (56.8%), MA (49.2%), NFLX (20.7%)
Total Yield4.4%JPM (6.6%), XOM (9.7%), JNJ (8.2%), BAC (6.8%), BABA (36.3%)
 Best Bets In Information Technology Sector
 CCRDVRSN NVDA RMBS QLYS ADBE YOU GEN IDCC DBX KLAC
What You Pay           
P/E22.927.157.150.724.320.616.527.022.216.139.5
P/EBIT17.819.649.043.222.716.519.69.917.713.732.4
What You Get           
Rev Chg Q27.5%7.3%55.6%22.7%10.3%10.7%17.5%30.3%34.5%-1.4%23.6%
Rev Chg LTM23.6%5.5%71.6%31.0%9.6%10.7%19.8%10.6%21.8%-0.0%23.9%
Rev Chg 3Y Avg0.9%5.2%92.0%17.3%12.5%10.5%35.5%14.8%23.3%4.1%10.4%
FCF/Rev 3Y Avg13.7%57.4%41.3%39.3%39.0%37.7%37.3%35.9%35.1%32.9%31.1%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 24%, alpha of 2.9%, and sharpe of 1.04

Latest Trefis Analyses

TitleTopic
0DASHBOARDS 
1How Low Can CoreCard Stock Really Go?Return

Trade Ideas

Select past ideas related to CCRD. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for CoreCard

Financials

CCRDADSKHITBIYABLIVBMRMedian
NameCoreCard Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Price23.60300.772.610.303.602.593.10
Mkt Cap0.264.10.1---0.2
Rev LTM656,60527---65
Op Inc LTM101,5151---10
FCF LTM91,8471---9
FCF 3Y Avg91,704----856
CFO LTM141,9254---14
CFO 3Y Avg141,775----894

Growth & Margins

CCRDADSKHITBIYABLIVBMRMedian
NameCoreCard Autodesk Health I.Baiya In.BeLive Beamr Im. 
Rev Chg LTM23.6%13.8%29.7%---23.6%
Rev Chg 3Y Avg0.9%11.7%----6.3%
Rev Chg Q27.5%17.1%86.2%---27.5%
QoQ Delta Rev Chg LTM6.2%4.1%19.3%---6.2%
Op Mgn LTM15.9%22.9%5.0%---15.9%
Op Mgn 3Y Avg12.0%21.5%----16.7%
QoQ Delta Op Mgn LTM1.5%0.8%-0.1%---0.8%
CFO/Rev LTM21.9%29.1%13.5%---21.9%
CFO/Rev 3Y Avg22.8%30.7%----26.8%
FCF/Rev LTM13.8%28.0%4.9%---13.8%
FCF/Rev 3Y Avg13.7%29.5%----21.6%

Valuation

CCRDADSKHITBIYABLIVBMRMedian
NameCoreCard Autodesk Health I.Baiya In.BeLive Beamr Im. 
Mkt Cap0.264.10.1---0.2
P/S2.89.75.4---5.4
P/EBIT17.845.373.1---45.3
P/E22.961.4106.2---61.4
P/CFO13.033.340.2---33.3
Total Yield4.4%1.6%0.9%---1.6%
Dividend Yield0.0%0.0%0.0%---0.0%
FCF Yield 3Y Avg3.9%3.3%----3.6%
D/E0.00.00.0---0.0
Net D/E-0.20.0-0.1----0.1

Returns

CCRDADSKHITBIYABLIVBMRMedian
NameCoreCard Autodesk Health I.Baiya In.BeLive Beamr Im. 
1M Rtn-12.3%-5.3%-18.7%-48.0%-1.1%-15.4%-13.8%
3M Rtn-18.5%-0.8%26.1%-56.5%36.4%-14.8%-7.8%
6M Rtn21.2%10.0%328.6%-93.3%-18.0%5.3%7.6%
12M Rtn68.8%4.1%----20.2%4.1%
3Y Rtn-3.7%40.3%----18.3%
1M Excs Rtn-14.7%-6.4%-21.8%-50.8%-4.9%-16.7%-15.7%
3M Excs Rtn-24.2%-8.1%21.1%-65.8%43.8%-23.6%-15.9%
6M Excs Rtn-0.5%-11.8%306.8%-115.1%-39.7%-16.5%-14.1%
12M Excs Rtn53.1%-12.2%----41.0%-12.2%
3Y Excs Rtn-73.0%-37.4%-----55.2%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/14/20255/8/20252/28/202510/31/20248/1/20245/2/20243/1/202411/1/20238/2/20235/4/20233/2/202311/2/2022
Key Financials Quarterly            
Total Revenue181715161413121316151614
Ebitda443422225453
Operating Income332311003232
Net Income2222100-02111
EPS0.250.240.250.280.110.050.06-0.030.220.150.120.16
Key Financials TTM            
Total Revenue TTM656157555254566061607067
Ebitda TTM1412109710121516162625
Operating Income TTM1097524589102020
Net Income TTM87542334561416
Growth Rates Quarterly            
Total Revenue Growth27.5%27.6%21.9%17.2%-12.1%-11.4%-23.2%-7.3%3.2%-39.2%21.3%11.7%
EBITDA Growth71.3%128.9%74.8%105.4%-55.8%-55.8%-67.8%-41.2%3.8%-73.1%23.5%-29.1%
Operating Income Growth131.8%432.6%425.8%574.3%-57.2%-71.0%-87.0%-75.7%-22.6%-84.5%0.2%-48.5%
Net Income Growth121.4%343.3%296.3%1089.2%-52.2%-65.8%-51.2%-116.3%-34.3%-85.5%-62.6%-46.4%
Margins Quarterly            
EBITDA Margin20.0%21.3%19.3%23.1%14.9%11.9%13.5%13.2%29.6%23.8%32.2%20.8%
Operating Income Margin15.1%16.8%14.0%17.7%8.3%4.0%3.2%3.1%17.1%12.3%19.2%11.8%
Net Income Margin11.3%11.4%13.0%14.0%6.5%3.3%4.0%-1.7%11.9%8.5%6.3%9.4%
Cash & Debt            
Total Cash322825282829323736272528
Total Debt322221112222
Net Debt / (Cash)-29-26-23-26-26-28-31-35-35-25-23-26
Cash Flows Quarterly            
FCF from Operations651321-13123-19
Cash Flows TTM            
FCF from Operations TTM141064414171724121023
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-02222210-001
Return on Invested Capital (ROIC) Quarterly            
ROIC------------
Return on Invested Capital (ROIC) TTM            
ROIC TTM------------

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Services5454423229
Products216646
Total5670483634


Price Behavior

CCRD Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta1.291.631.241.040.990.74
Up Beta3.241.652.111.441.251.01
Down Beta2.942.752.820.710.850.64
Up Capture19%72%15%92%113%23%
Bmk +ve Days13233574144420
Stock +ve Days8192961126383
Down Capture145%210%102%50%65%85%
Bmk -ve Days8192952107330
Stock -ve Days12223262122361

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity218,711
Short Interest: % Change Since 9302025-16.3%
Average Daily Volume50,145
Days-to-Cover Short Interest4.36
Basic Shares Quantity7,790,481
Short % of Basic Shares2.8%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/14/2025-1.4%-4.1%-4.3%
5/8/202515.2%39.3%61.0%
2/20/20253.1%-4.3%-6.9%
10/31/20247.4%18.2%50.1%
8/1/20243.2%2.1%22.0%
5/2/20245.0%10.2%15.4%
2/14/2024-6.2%-6.4%-11.2%
11/1/2023-21.9%-25.9%-39.0%
...
SUMMARY STATS   
# Positive101110
# Negative141314
Median Positive4.1%8.4%19.8%
Median Negative-2.3%-5.1%-8.7%
Max Positive15.2%39.3%61.0%
Max Negative-21.9%-25.9%-39.0%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025814202510-Q 6/30/2025
3312025508202510-Q 3/31/2025
12312024228202510-K 12/31/2024
93020241031202410-Q 9/30/2024
6302024801202410-Q 6/30/2024
3312024502202410-Q 3/31/2024
12312023301202410-K 12/31/2023
93020231101202310-Q 9/30/2023
6302023802202310-Q 6/30/2023
3312023504202310-Q 3/31/2023
12312022302202310-K 12/31/2022
93020221102202210-Q 9/30/2022
6302022803202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021303202210-K 12/31/2021
93020211104202110-Q 9/30/2021

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.